Advertisement
Screener

ARTELO BIOSCIENCES, INC. (ARTL) Weighted Average Number of Shares Outstanding, Basic and Diluted

2.8 / 5 stars · 68/120 Roast Me

ARTELO BIOSCIENCES, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted

ARTELO BIOSCIENCES, INC. (ARTL) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 33.45 billion shares for the 4-month period ending 2021-12-31, per its 10-KT filed 2022-03-21.

Discontinued › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-21

  • ARTELO BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-11-30 was 30.44B shares, a 197.90% increase year-over-year.
  • ARTELO BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-08-31 was 24.35M shares, a 99.84% decline year-over-year.
  • ARTELO BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-05-31 was 23.11M shares, a 566.72% increase year-over-year.
  • ARTELO BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-02-28 was 16.99M shares, a 395.84% increase year-over-year.
  • ARTELO BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 18.68M shares, a 99.50% decline from fiscal 2020.
  • ARTELO BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 3.71B shares, a 170565.58% increase from fiscal 2019.
  • ARTELO BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 2.17M shares, a 78.74% decline from fiscal 2018.
  • ARTELO BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 10.22M shares, a 17.04% increase from fiscal 2017.
Period endWeighted Average Number of Shares Outstanding, Basic and Diluted 3 monthWeighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filedWeighted Average Number of Shares Outstanding, Basic and Diluted 4 monthWeighted Average Number of Shares Outstanding, Basic and Diluted 6 monthWeighted Average Number of Shares Outstanding, Basic and Diluted 9 monthWeighted Average Number of Shares Outstanding, Basic and Diluted 12 monthWeighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed
2021-12-3133.45B shares
10-KT · filed 2022-03-21
2021-11-3030.44B shares
10-Q · filed 2022-01-12
15.23B shares
derived: average of 2 quarters · filed 2022-03-21
10.16B shares
derived: average of 3 quarters · filed 2022-03-21
7.63B shares
derived: average of 4 quarters · filed 2022-03-21
2021-08-3124.35M shares
derived: 10-KT 12 month − 10-Q 9 month · filed 2022-03-21
23.73M shares
derived: average of 2 quarters · filed 2022-03-21
21.48M shares
derived: average of 3 quarters · filed 2022-03-21
18.68M shares
10-KT · filed 2022-03-21
18.68B shares
10-K · filed 2021-11-29
2021-05-3123.11M shares
10-Q · filed 2021-07-12
20.05M shares
derived: average of 2 quarters · filed 2021-07-12
16.78M shares
10-Q · filed 2021-07-12
6.27B shares
derived: average of 4 quarters · filed 2022-03-21
2021-02-2816.99M shares
10-Q · filed 2021-04-13
13.57M shares
10-Q · filed 2021-04-13
8.35B shares
derived: average of 3 quarters · filed 2022-03-21
6.26B shares
derived: average of 4 quarters · filed 2022-03-21
2020-12-3111.46M shares
10-KT · filed 2022-03-21
2020-11-3010.22B shares
10-Q · filed 2022-01-12
10.22M shares
10-Q · filed 2021-01-14
12.52B shares
derived: average of 2 quarters · filed 2022-03-21
8.35B shares
derived: average of 3 quarters · filed 2022-03-21
6.26B shares
derived: average of 4 quarters · filed 2022-03-21
2020-08-3114.82B shares
derived: 10-KT 12 month − 10-Q 9 month · filed 2022-03-21
7.41B shares
derived: average of 2 quarters · filed 2022-03-21
4.94B shares
derived: average of 3 quarters · filed 2022-03-21
3.71B shares
10-KT · filed 2022-03-21
3.71M shares
10-K · filed 2020-11-04
2020-05-313.47M shares
10-Q · filed 2021-07-12
3.45M shares
derived: average of 2 quarters · filed 2021-07-12
3.42M shares
10-Q · filed 2021-07-12
3.31M shares
derived: average of 4 quarters · filed 2021-07-12
2020-02-293.43M shares
10-Q · filed 2021-04-13
3.39M shares
10-Q · filed 2021-04-13
3.26M shares
derived: average of 3 quarters · filed 2021-04-13
2.96M shares
derived: average of 4 quarters · filed 2021-04-13
2019-11-303.36M shares
10-Q · filed 2021-01-14
3.18M shares
derived: average of 2 quarters · filed 2021-01-14
2.81M shares
derived: average of 3 quarters · filed 2021-01-14
5.94M shares
derived: average of 4 quarters · filed 2021-01-14
2019-08-313.00M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-04
2.53M shares
derived: average of 2 quarters · filed 2020-11-04
6.80M shares
derived: average of 3 quarters · filed 2020-11-04
2.17M shares
10-K · filed 2020-11-04
2019-05-312.06M shares
10-Q · filed 2020-07-13
8.70M shares
derived: average of 2 quarters · filed 2020-07-13
1.90M shares
10-Q · filed 2020-07-13
9.12M shares
derived: average of 4 quarters · filed 2020-07-13
2019-02-2815.34M shares
10-Q · filed 2019-04-15
14.68M shares
10-Q · filed 2019-04-15
11.47M shares
derived: average of 3 quarters · filed 2019-04-15
11.79M shares
derived: average of 4 quarters · filed 2019-04-15
2018-11-3014.04M shares
10-Q · filed 2019-01-14
9.53M shares
derived: average of 2 quarters · filed 2019-01-14
10.60M shares
derived: average of 3 quarters · filed 2019-01-14
10.87M shares
derived: average of 4 quarters · filed 2019-04-15
2018-08-315.03M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-29
8.89M shares
derived: average of 2 quarters · filed 2018-11-29
9.82M shares
derived: average of 3 quarters · filed 2019-04-15
10.22M shares
10-K · filed 2018-11-29
2018-05-3112.74M shares
10-Q · filed 2018-07-13
12.21M shares
derived: average of 2 quarters · filed 2019-04-15
11.95M shares
10-Q · filed 2018-07-13
11.65M shares
derived: average of 4 quarters · filed 2019-04-15
2018-02-2811.68M shares
10-Q · filed 2019-04-15
11.56M shares
10-Q · filed 2019-04-15
11.28M shares
derived: average of 3 quarters · filed 2019-04-15
10.67M shares
derived: average of 4 quarters · filed 2019-04-15
2017-11-3011.35M shares
10-Q · filed 2019-01-14
11.09M shares
derived: average of 2 quarters · filed 2019-01-14
10.33M shares
derived: average of 3 quarters · filed 2019-01-14
9.66M shares
derived: average of 4 quarters · filed 2019-01-14
2017-08-3110.83M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-29
9.82M shares
derived: average of 2 quarters · filed 2018-11-29
9.09M shares
derived: average of 3 quarters · filed 2018-11-29
8.73M shares
10-K · filed 2018-11-29
2017-05-318.81M shares
10-Q · filed 2018-07-13
8.22M shares
derived: average of 2 quarters · filed 2018-07-13
8.03M shares
10-Q · filed 2018-07-13
7.93M shares
derived: average of 4 quarters · filed 2018-07-13
2017-02-287.64M shares
10-Q/A · filed 2018-05-14
7.64M shares
10-Q/A · filed 2018-05-14
7.64M shares
derived: average of 3 quarters · filed 2018-05-14
7.64M shares
derived: average of 4 quarters · filed 2018-05-14
2016-11-307.64M shares
10-Q/A · filed 2018-03-21
7.64M shares
derived: average of 2 quarters · filed 2018-03-21
7.64M shares
derived: average of 3 quarters · filed 2018-03-21
7.64M shares
derived: average of 4 quarters · filed 2018-03-21
2016-08-317.64M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-29
7.64M shares
derived: average of 2 quarters · filed 2017-11-29
7.64M shares
derived: average of 3 quarters · filed 2017-11-29
7.64M shares
10-K · filed 2017-11-29
2016-05-317.64M shares
10-Q · filed 2017-07-21
7.64M shares
derived: average of 2 quarters · filed 2017-07-21
7.64M shares
10-Q · filed 2017-07-21
7.56M shares
derived: average of 4 quarters · filed 2017-07-21
2016-02-297.64M shares
10-Q · filed 2017-04-14
7.64M shares
10-Q · filed 2017-04-14
7.53M shares
derived: average of 3 quarters · filed 2017-04-14
7.23M shares
derived: average of 4 quarters · filed 2017-04-14
2015-11-307.64M shares
10-Q · filed 2017-01-10
7.47M shares
derived: average of 2 quarters · filed 2017-01-10
7.09M shares
derived: average of 3 quarters · filed 2017-01-10
6.82M shares
derived: average of 4 quarters · filed 2017-01-10
2015-08-317.31M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-29
6.81M shares
derived: average of 2 quarters · filed 2016-11-29
6.54M shares
derived: average of 3 quarters · filed 2016-11-29
6.41M shares
10-K · filed 2016-11-29
2015-05-316.31M shares
10-Q · filed 2016-07-05
6.16M shares
derived: average of 2 quarters · filed 2016-07-05
6.11M shares
10-Q · filed 2016-07-05
6.09M shares
derived: average of 4 quarters · filed 2016-07-05
2015-02-286.00M shares
10-Q · filed 2016-04-01
6.00M shares
10-Q · filed 2016-04-01
6.01M shares
derived: average of 3 quarters · filed 2016-01-14
6.01M shares
derived: average of 4 quarters · filed 2016-01-14
2014-11-306.00M shares
10-Q · filed 2016-01-14
6.02M shares
derived: average of 2 quarters · filed 2016-01-14
6.01M shares
derived: average of 3 quarters · filed 2016-01-14
4.53M shares
derived: average of 4 quarters · filed 2016-01-14
2014-08-316.03M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11
6.02M shares
derived: average of 2 quarters · filed 2015-12-11
4.04M shares
derived: average of 3 quarters · filed 2015-12-11
3.07M shares
10-K · filed 2015-12-11
2014-05-316.00M shares
10-Q · filed 2015-07-15
3.05M shares
derived: average of 2 quarters · filed 2015-07-15
2.09M shares
10-Q · filed 2015-07-15
2014-02-2899.45K shares
10-Q · filed 2015-04-14
99.45K shares
10-Q · filed 2015-04-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87
NextCure, Inc. (NXTC)United States$0.024B-0.15
Cocrystal Pharma, Inc. (COCP)United States$0.022B
AYTU BIOPHARMA, INC (AYTU)United States$0.025B-1.62
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77
Marker Therapeutics, Inc. (MRKR)United States$0.020B-2.86
Cellectar Biosciences, Inc. (CLRB)United States$0.020B-1.03
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Rocket One Inc. (RKTO)United States$0.019B